These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27643697)

  • 1. Changes in insulin-like growth factor signaling alter phenotypes in Fragile X Mice.
    Wise TL
    Genes Brain Behav; 2017 Feb; 16(2):241-249. PubMed ID: 27643697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X syndrome: From protein function to therapy.
    Bagni C; Oostra BA
    Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.
    Pacey LK; Doss L; Cifelli C; van der Kooy D; Heximer SP; Hampson DR
    Mol Cell Neurosci; 2011 Mar; 46(3):563-72. PubMed ID: 21215802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
    Gao MM; Shi H; Yan HJ; Long YS
    J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
    Mol Autism; 2016; 7():17. PubMed ID: 26933487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau reduction attenuates autism-like features in Fmr1 knockout mice.
    Zhao S; Jiang X; Han L; Jiang Y; Wang Y; Meng J; Zhu X; Zhang X; Luo H; Zhang YW
    Mol Autism; 2023 Nov; 14(1):42. PubMed ID: 37936174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine acetylome profiling in mouse hippocampus and its alterations upon FMRP deficiency linked to abnormal energy metabolism.
    Wu YY; Yang C; Yan HJ; Lu P; Zhang L; Feng WC; Long YS
    J Proteomics; 2022 Oct; 269():104720. PubMed ID: 36089189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice.
    Sawicka K; Pyronneau A; Chao M; Bennett MV; Zukin RS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6290-E6297. PubMed ID: 27663742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice.
    Santini E; Huynh TN; Longo F; Koo SY; Mojica E; D'Andrea L; Bagni C; Klann E
    Sci Signal; 2017 Nov; 10(504):. PubMed ID: 29114037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
    Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
    Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.
    Hoeffer CA; Sanchez E; Hagerman RJ; Mu Y; Nguyen DV; Wong H; Whelan AM; Zukin RS; Klann E; Tassone F
    Genes Brain Behav; 2012 Apr; 11(3):332-41. PubMed ID: 22268788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle.
    Saré RM; Levine M; Smith CB
    eNeuro; 2016; 3(2):. PubMed ID: 27294193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
    Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
    Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome.
    Rogers TD; Anacker AMJ; Kerr TM; Forsberg CG; Wang J; Zhang B; Veenstra-VanderWeele J
    Mol Autism; 2017; 8():30. PubMed ID: 28649315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.